Tri-Mix 18/1/10 (Papaverine 18mg, Phentolamine 1 mg, Prostaglandin 10 mcg/mL) packaged in 2.5 mL ...
FDA Drug Recall #D-0004-2017 — Class II — September 12, 2016
Recall Summary
| Recall Number | D-0004-2017 |
| Classification | Class II — Moderate risk |
| Date Initiated | September 12, 2016 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | The Apothecary Shoppe LLC |
| Location | Tulsa, OK |
| Product Type | Drugs |
| Quantity | 247.5 mL total volume |
Product Description
Tri-Mix 18/1/10 (Papaverine 18mg, Phentolamine 1 mg, Prostaglandin 10 mcg/mL) packaged in 2.5 mL sterile vials, IM, Rx, The Apothecary Shoppe, Jenks, OK
Reason for Recall
Lack of Assurance of Sterility; medication was sterilized with a recalled filter
Distribution Pattern
Oklahoma
Lot / Code Information
07252016@22 BUD 09/22/2016; 08102016@28 BUD 10/08/2016
Other Recalls from The Apothecary Shoppe LLC
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0002-2017 | Class II | Methylcobalamin 5000 mcg/mL Injection, packaged... | Sep 12, 2016 |
| D-0003-2017 | Class II | Phenotolamine 0.4mg/Prostaglandin 20mcg/mL pack... | Sep 12, 2016 |
| D-1312-2015 | Class II | SO-Acetylcysteine 10% Sterile Ophthalmic Soluti... | Jun 26, 2015 |
| D-1303-2015 | Class II | SIU-Tri-Mix 18/1/20 Injection, Rx Only, 10 mL V... | Jun 26, 2015 |
| D-1290-2015 | Class II | S-Chorionic Gonad HCG 1000 U/mL Injection, Rx O... | Jun 26, 2015 |
Frequently Asked Questions
Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.